ArticlePloS one2026
Cervical cancer screening coverage and associated factors among women aged 25-59 in Eswatini: Insights from the 2021 Population-Based HIV Impact Assessment (PHIA).
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer is the most common cancer and the leading cause of cancer mortality among women in Eswatini, which reported the highest cervical cancer incidence and mortality rates globally in 2022. However, recent nationally representative published data on cervical cancer screening coverage in Eswatini remain limited. This study aimed to estimate cervical cancer screening coverage and identify factors associated with screening uptake among women aged 25-59 years in Eswatini.
methodData were drawn from the 2021 Eswatini Population-based HIV Impact Assessment (PHIA), a nationally representative cross-sectional household survey. Survey-weighted bivariable and multivariable logistic regression analyses were conducted to identify factors associated with screening uptake. Results are reported as adjusted odds ratios (AORs) with 95% confidence intervals (CIs).
resultAmong 3,192 women aged 25-59 years, 48.2% reported ever having undergone cervical cancer screening. Higher odds of screening were observed among women living with HIV (AOR 2.26, 95% CI 1.93-2.65), those aged 36-45 years (AOR 1.35, 95% CI 1.12-1.62), and those in the fourth wealth quintile (AOR 1.40, 95% CI 1.05-1.88). Lower odds of screening were observed among women who were not married (AOR 0.65, 95% CI 0.54-0.78), with no formal education (AOR 0.56, 95% CI 0.39-0.80), no recent healthcare visit (AOR 0.67, 95% CI 0.55-0.83), no family planning use (AOR 0.82, 95% CI 0.69-0.97), and one sexual partners (AOR 0.78, 95% CI 0.65-0.94).
conclusionDespite notable progress, cervical cancer screening coverage in Eswatini remains below World Health Organization targets. Enhancing community awareness, addressing stigma and structural barriers, and integrating cervical cancer screening into routine and reproductive healthcare services may accelerate progress toward achieving the WHO 2030 targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.